GlycoMar Limited

GlycoMar is a biotechnology company discovering and developing products for the healthcare and personal care markets.

GlycoMar Limited

The company, founded in 2005, has an established discovery platform technology based on marine natural products, which generates valuable intellectual property.

GlycoMar is developing novel pharmaceutical products for the treatment of inflammatory disorders such as psoriasis, asthma, and inflammatory bowel disease. The company is also developing cosmetic ingredients for the skincare market. Our development programme is being carried out both in house and with commercial partners.

GlycoMar seeks to develop its discoveries to generate value throughout licensing. The value of GlycoMar's technology has been demonstrated through early stage Licensing and Collaboration deals.


European Centre for Marine Biotechnology
Dunstaffnage Marine Laboratory
PA37 1QA